HOWL MEXC RealStocks
Own real HOWL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1

Last updated: 2026-11-13 15:06:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Werewolf Therapeutics, Inc. (HOWL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.99, with a market capitalization of $47.63M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.27 to $1.20. This page covers its latest market performance, valuation, price trends and company information.
$47.63M | |
$0.98 | |
$1.02 | |
$0.98 | |
$0.98 | |
60.36K | |
6.78M | |
-- | |
$1.20 | |
$0.27 | |
-- | |
-- |
Werewolf Therapeutics, Inc. (HOWL) is currently trading at $0.99 as of 2026-11-13 15:05:00, up 0.55% ($0.01) from the previous close of $0.98
During today's regular trading session, HOWL has traded between $0.98 and $1.02, with a trading volume of 60.36K shares. The current price is near the middle of today's range.
Over the past seven days, Werewolf Therapeutics, Inc. (HOWL) moved from $1.02 to $0.99, representing a decline of 2.65% ($0.03).
The stock traded between $0.97 and $1.07 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 191.12 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 77.7%
HOWL is currently trading at $0.99, placing it 77.7% of the way from its 52-week low of $0.27 to its 52-week high of $1.20. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Werewolf Therapeutics, Inc. (HOWL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to HOWL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between HOWL shares and USD.
HOWL Shares to USD
1.00 HOWL shares = 0.993 USD
Calculations are estimates based on the latest available price and are for reference only.